Does anticholinergic medication use on presentation to a rural memory clinic predict cognitive or functional decline over one year?
Journal of Alzheimer’s Disease · 2026-04 · 110 (3) · 1490-1495
DOI: 10.1177/13872877261424232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 09.03.2026. Verfasst von Devin Proulx und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada. Hauptthemen laut MEDLINE: Cholinergic Antagonists, Dementia, Cognitive Dysfunction, Cognition Disorders. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Anticholinergic medications carry increased risk of worsening cognition, particularly in patients with dementia.
Objective
Cognitive and functional scores of patients were compared at 1-year follow up after cessation of prior anticholinergic medications to those who were not taking anticholinergics at baseline to assess whether prior anticholinergic use affected dementia prognosis in memory clinic patients.
Methods
Longitudinal data from 578 consecutive patients with diagnoses including Alzheimer's disease (AD), frontotemporal and vascular dementia, Lewy body dementia, mild cognitive impairment and dementia due to non-AD etiologies compared patients taking anticholinergic drugs to those taking none at intake. Anticholinergic drugs were discontinued in all patients at initial visit. Mini-Mental Status Examination (MMSE) and Functional Activities Questionnaire (FAQ) were administered at intake and 1-year follow up.
Results
Between the no-anticholinergic and anticholinergic groups, MMSE at baseline did not significantly differ when the entire sample was compared. In addition, MMSE score change between baseline and follow-up did not significantly differ. Similarly, no significant differences were observed between groups in FAQ at baseline or in FAQ change between timepoints. Subgroup analysis of only those with AD yielded statistically significant differences in initial MMSE. However, these groups had statistically similar follow-up MMSE. Although initial FAQ scores were similar, there were significant differences in follow-up FAQ in patients with AD.
Conclusions
Findings suggest that patients with AD presenting on anticholinergic medications may do worse cognitively and functionally than those who were never on anticholinergics despite baseline discontinuation. Anticholinergic medication use in older adults should be approached cautiously.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
- Department of Neurology, University of Saskatchewan, Saskatoon, SK, Canada.
- Department of Psychology & Health Studies, University of Saskatchewan, Saskatoon, SK, Canada.
- Canadian Centre for Rural and Agricultural Health, University of Saskatchewan, Saskatoon, SK, Canada.
ORCID-Profile: Devin Proulx
Zitieren
APA
Proulx, D., Kirk, A., O'Connell, M., & Morgan, D. (2026). Does anticholinergic medication use on presentation to a rural memory clinic predict cognitive or functional decline over one year?. Journal of Alzheimer’s Disease, 110(3), 1490-1495. https://doi.org/10.1177/13872877261424232
Vancouver
Proulx D, Kirk A, O'Connell M, Morgan D. Does anticholinergic medication use on presentation to a rural memory clinic predict cognitive or functional decline over one year?. Journal of Alzheimer’s Disease. 2026;110(3):1490-1495. doi:10.1177/13872877261424232
BibTeX
@article{Proulx2026,
author = {Proulx, Devin and Kirk, Andrew and O'Connell, Megan and Morgan, Debra},
title = {Does anticholinergic medication use on presentation to a rural memory clinic predict cognitive or functional decline over one year?},
journal = {Journal of Alzheimer’s Disease},
year = {2026},
volume = {110},
number = {3},
pages = {1490--1495},
doi = {10.1177/13872877261424232}
}
EUVIMED